Zhu Y - Search Results

1

Effect of tacrolimus on soluble costimulatory molecules in patients with refractory myasthenia gravis.

Wu H, Chen L, Zhou X, Wu Y, Yan Y, Zhu Y, Zhao C, Xue Q. Wu H, et al. Among authors: zhu y. J Neuroimmunol. 2022 Nov 15;372:577955. doi: 10.1016/j.jneuroim.2022.577955. Epub 2022 Aug 27. J Neuroimmunol. 2022. PMID: 36054935

2

PD-1 blockade combined with IL-33 enhances the antitumor immune response in a type-1 lymphocyte-mediated manner.

He H, Shi L, Meng D, Zhou H, Ma J, Wu Y, Wu Y, Gu Y, Xie W, Zhang J, Zhu Y. He H, et al. Among authors: zhu y. Cancer Treat Res Commun. 2021;28:100379. doi: 10.1016/j.ctarc.2021.100379. Epub 2021 Apr 23. Cancer Treat Res Commun. 2021. PMID: 33951555 Free article.

3

Eomes Impedes Durable Response to Tumor Immunotherapy by Inhibiting Stemness, Tissue Residency, and Promoting the Dysfunctional State of Intratumoral CD8⁺ T Cells.

Sun R, Wu Y, Zhou H, Wu Y, Yang Z, Gu Y, Jiang J, Lu B, Zhu Y. Sun R, et al. Among authors: zhu y. Front Cell Dev Biol. 2021 Jan 21;9:640224. doi: 10.3389/fcell.2021.640224. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33553191 Free PMC article.

4

[Influence of co-stimulatory molecules B7-H4 expression on the prognosis of patients with gastric cancer treated with cytokine-induced killer cells adoptive immunotherapy].

Jiang JT, Wu CP, Shen YP, Zheng L, Wu J, Ji M, Xu B, Chen LJ, Wu YG, Zheng X, Zhu YB, Lu BF, Zhang XG. Jiang JT, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2010 May;13(5):366-70. Zhonghua Wei Chang Wai Ke Za Zhi. 2010. PMID: 20499308 Chinese.

5

[IL-33 enhances cytokine secretion and killing function of peripheral blood mononuclear cells in vitro].

Li X, Lyu Q, Xia R, Gu Y, Gao T, Yu P, Zhang X, Zhu Y. Li X, et al. Among authors: zhu y. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015 Sep;31(9):1246-50. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015. PMID: 26359105 Chinese.

6

Clinical Significance of Dynamics of Programmed Death Ligand-1 Expression on Circulating CD14⁺ Monocytes and CD19⁺ B Cells with the Progression of Hepatitis B Virus Infection.

Huang ZY, Xu P, Li JH, Zeng CH, Song HF, Chen H, Zhu YB, Song YY, Lu HL, Shen CP, Zhang XG, Wu MY, Wang XF. Huang ZY, et al. Viral Immunol. 2017 Apr;30(3):224-231. doi: 10.1089/vim.2016.0122. Epub 2016 Dec 22. Viral Immunol. 2017. PMID: 28005469

7

[Up-regulation of TIM-3 on CD4+ tumor infiltrating lymphocytes predicts poor prognosis in human non-small-cell lung cancer].

Ji P, Chen D, Bian J, Xia R, Song X, Wen W, Zhang X, Zhu Y. Ji P, et al. Among authors: zhu y. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015 Jun;31(6):808-11. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015. PMID: 26062425 Chinese.

8

[The Expression and Biological Significance of PD-L1 on Lung Cancer Cell Lines.].

Chen C, Mu C, Qu Q, Zhu Y, Sun J, Zhang X, Huang J. Chen C, et al. Among authors: zhu y. Zhongguo Fei Ai Za Zhi. 2009 Aug 20;12(8):859-63. doi: 10.3779/j.issn.1009-3419.2009.08.05. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20719171 Free article. Chinese.

9

Tim-3 is highly expressed in T cells in acute myeloid leukemia and associated with clinicopathological prognostic stratification.

Li C, Chen X, Yu X, Zhu Y, Ma C, Xia R, Ma J, Gu C, Ye L, Wu D. Li C, et al. Among authors: zhu y. Int J Clin Exp Pathol. 2014 Sep 15;7(10):6880-8. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25400771 Free PMC article.

10

Association between interleukin-36γ and tumor progression in non-small cell lung cancer.

Liu L, He H, Xu D, Feng Y, Zhou H, Shi L, Gu Y, Wang J, Zhu Y. Liu L, et al. Among authors: zhu y. Oncol Lett. 2020 Mar;19(3):2457-2465. doi: 10.3892/ol.2020.11319. Epub 2020 Jan 17. Oncol Lett. 2020. PMID: 32194745 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54,034 results

Search Page

Filters